Equities News

Followers (31)

Following (13)

Equities Staff $equitiesstaff

The Equities staff is devoted to creating informational and educational content for investors and traders to better understand the financial markets. Equities.com is the leading financial media website that combines cutting-edge social networking capabilities

Articles (694)

Article's title	Publish date
Squarespace Beats Revenue Estimates With Record Q1	May 12, 2022
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement	May 11, 2022
WHO Endorses Pfizer's Oral COVID-19 Treatment Paxlovid for High-Risk Patients	Apr 22, 2022
Aviat Networks To Acquire Redline Communications	Apr 14, 2022
Bird Construction Awarded C$90 Million in New Contracts	Apr 5, 2022
Skippy Recalls Over 161,000 Pounds of Peanut Butter for Possible Steel Fragments	Mar 31, 2022
Supreme Court Justice Thomas's Wife Virginia Urged Overturning 2020 Election	Mar 25, 2022
Study Finds NCAA Basketball Tournament Costs Businesses $13.8 Billion in Lost Productivity Each Year	Mar 18, 2022
Ukraine's Leading Neon Suppliers Halt Production of Half of World's Semiconductor Grade Neon	Mar 11, 2022
Global Pharmaceutical Companies Pledge Support for Ukraine's Healthcare System	Mar 4, 2022

Page 1 of 70

There are no recent news available for Equities Staff.

Equities Staff $equitiesstaff

Show More

Today's Must Reads

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold

The Best Laid Plans of Mice and Men — Part I

Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users

Squarespace Beats Revenue Estimates With Record Q1

BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million

How To Trade in a Bearish Market

AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Cigna Beats Q1 Revenue and Earnings Estimates, Raises Full Year Guidance

PepGen Goes Public in $108 Million IPO

Bausch + Lomb Raises $630 Million in IPO, Missing Expectations

Aeglea BioTherapeutics Raises $45 Million Via Registered Direct Offering

Biogen CEO Michel Vounatsos To Step Down After Commercial Failure of Alzheimer's Drug

RELEASING NOV-25: Greenwich Economic Forum (Full Event Coverage)